Back to Search
MATTHEW RALSTIN, M.D.
M.D.
Ophthalmology Physician
NPI: 1104088731IndividualAccepts Medicare
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2007
Research & Publications (5)
Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
PMID 16778086·Mol Cancer Res·2006
8-other
Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
PMID 18815538·Pancreas·2008
7-preclinical
PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia.
PMID 18027059·J Gastrointest Surg·2008
8-other
Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.
PMID 17950089·J Surg Res·2007
7-preclinical
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
PMID 17541034·Mol Cancer Ther·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 2251 DUBOIS DR
WARSAW, IN 46580 - Phone
- (574) 269-2777
Quick Facts
- NPI
- 1104088731
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 5
Are you this provider?
Claim Your Profile